Pathogenic and likely pathogenic germline variants in the BRCA1 and BRCA2 genes play a pivotal role in breast cancer development and progression and can determine the optimal risk-reducing strategies and personalized case management for the carriers of such variants. Here, BRCA2 is linked to breast cancer.